# EDGAR Filing Document

**Accession Number:** 0001951070
**File Stem:** 0001951070-26-000021
**Filing Date:** 2026-6
**Character Count:** 61730
**Document Hash:** a7cf89348830771ad417fd42a3becee4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001951070-26-000021.hdr.sgml**: 20260611

**ACCESSION NUMBER**: 0001951070-26-000021

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260611

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260611

**DATE AS OF CHANGE**: 20260611

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** McGraw Hill, Inc.
- **CENTRAL INDEX KEY:** 0001951070
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS PUBLISHING [2741]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 871259704
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42764
- **FILM NUMBER:** 261081435

**BUSINESS ADDRESS:**
- **STREET 1:** C/O PLATINUM EQUITY ADVISORS, LLC
- **STREET 2:** 360 N. CRESCENT DRIVE, SOUTH BUILDING
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90210
- **BUSINESS PHONE:** 614 430 4000

**MAIL ADDRESS:**
- **STREET 1:** 8787 ORION PLACE
- **CITY:** COLUMBUS
- **STATE:** OH
- **ZIP:** 43240

?xml version='1.0' encoding='ASCII'? mh-20260611

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**___________________________________**

**FORM 8-K**

**___________________________________**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**June 11, 2026**

**Date of Report (date of earliest event reported)**

**___________________________________**

**McGraw Hill, Inc.**

**(Exact name of registrant as specified in its charter)**

**___________________________________**

---

| | | |
|:---|:---|:---|
| **Delaware**<br>**(State or other jurisdiction of** <br>**incorporation or organization)** | **001-42764**<br>**(Commission File Number)** | **87-1259704**<br>**(I.R.S. Employer Identification Number)** |
| **8787 Orion Place** <br>**Columbus, OH 43240**<br>(Address of principal executive offices and zip code) | **8787 Orion Place** <br>**Columbus, OH 43240**<br>(Address of principal executive offices and zip code) | **8787 Orion Place** <br>**Columbus, OH 43240**<br>(Address of principal executive offices and zip code) |
| **(Registrant's telephone number, including area code): (614) 430-4000** | **(Registrant's telephone number, including area code): (614) 430-4000** | **(Registrant's telephone number, including area code): (614) 430-4000** |

---

**___________________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| Common stock, par value $0.01 | MH | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 - Results of Operations and Financial Condition**

On June 11, 2026, McGraw Hill, Inc. (the "Company") issued a press release announcing its results for the fiscal fourth quarter and fiscal year ended March 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.

In accordance with General Instruction B.2 of Form 8-K, the information under this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information, including Exhibit 99.1, be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.

**Item 8.01 - Other Events**

On June 2, 2026, the Company's board of directors approved a share repurchase plan whereby, from time to time, the Company may repurchase up to $50.0 million of the Company's common stock.

**Item 9.01 - Financial Statements and Exhibits**

**(d): Exhibits.**

---

| | |
|:---|:---|
| **<u>Exhibit Number</u>** | **<u>Description</u>** |
| 99.1 | <u>[Press Release dated June 11, 2026](mh-2026331xpressreleaseex9.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **MCGRAW HILL, INC.** | **MCGRAW HILL, INC.** |
| By: | /s/ David Stafford |
| Name: | David Stafford |
| Title: | Executive Vice President, General Counsel, Secretary |

---

Date: June 11, 2026

## Exhibit 99.1

**McGraw Hill, Inc. Exceeds Fiscal Year 2026 Guidance Driven by Re-Occurring Revenue Growth and Delivers Positive Net Income**

***Fiscal Year 2027 Positioned for Revenue Growth and Accelerating Profitability***

COLUMBUS, Ohio—(BUSINESS WIRE)— June 11, 2026—McGraw Hill, Inc. (NYSE: MH) ("McGraw Hill" or the "Company"), a leading global provider of education solutions for preK-12, higher education and professional learning, today announced financial results for the fiscal fourth quarter 2026 and year-end March 31, 2026.

**Key Fiscal Year 2026 Financial Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;• Total revenue of $2,102.8 million, an increase of 0.1% year-over-year, driven by strong Higher Education execution, offsetting the anticipated smaller K-12 market opportunity driven by procurement cycles.

&nbsp;&nbsp;&nbsp;&nbsp;• Re-occurring revenue of $1,541.0 million, an increase of 5.8% year-over-year, representing more than 73% of total revenue.

&nbsp;&nbsp;&nbsp;&nbsp;• Digital revenue of $1,433.6 million, an increase of 5.5% year-over-year amid accelerating student and instructor engagement.

&nbsp;&nbsp;&nbsp;&nbsp;• Remaining performance obligation (RPO) of $1,671.4 million as of March 31, 2026 demonstrating predictability and visibility into future revenue growth.

&nbsp;&nbsp;&nbsp;&nbsp;• GAAP gross profit of $1,701.6 million, representing a GAAP gross profit margin of 80.9%, an increase of over 100 basis points versus prior year.

&nbsp;&nbsp;&nbsp;&nbsp;• GAAP net income (loss) of $35.3 million, compared to $(85.8) million in the prior-year period.

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(1)</sup> of $744.3 million, representing an Adjusted EBITDA margin<sup>(1)</sup> of 35.4%, an increase of nearly 80 basis points versus prior year.

&nbsp;&nbsp;&nbsp;&nbsp;• Reduction of gross debt by $645.6 million, including $50.0 million in the fiscal fourth quarter, at the beginning of the seasonal cash trough.

"McGraw Hill's growth in fiscal year 2026 underscores the strength of our strategy, the speed of our innovation and the depth of trust that we have from the education community," said Philip Moyer, President and Chief Executive Officer of the Company and a member of the Company's Board of Directors. "This past year, we released more new curriculum offerings and learning tools than during any time in our history, reached record engagement levels, and achieved a new high-water mark for customer satisfaction. We have achieved over 7.5 million users of our new AI personalized learning tools and now have an existing base of more than 100 million active student and educator curriculum licenses in over 100 countries. With over 25 billion learning interactions and 190 terabytes of data across our platforms, we are delivering a new generation of precision learning at a global scale that few can match. Equally exciting, we are preparing to pilot our new Agentic AI version of our precision education model, and we intend to be a leader in creating a vibrant 'cloud' knowledge offering in the world of education and learning. Our momentum in fiscal year 2026 positions us well to accelerate growth and expand margins in fiscal year 2027 and beyond."

"Fiscal year 2026 was a transformative year for McGraw Hill—marked by our initial public offering and the growth of our Company, notwithstanding a smaller K-12 market opportunity, expanding profitability and significant debt reduction," said Bob Sallmann, McGraw Hill's Executive Vice President and Chief Financial Officer. "Our disciplined execution delivered results above guidance across revenue, re-occurring revenue and Adjusted EBITDA while strengthening our balance sheet and cash generation. With $646 million in gross debt reduction, we have increased our financial flexibility and expanded margins while simultaneously investing in the business to position the Company for sustained long-term growth. As we enter fiscal year 2027, our focus remains on growth acceleration, operating efficiency and employing a balanced approach to capital allocation as we continue to reduce gross debt, grow the business and strengthen returns."

**Fiscal Year 2026 Strategic Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;• Served over 100 million active student and educator curriculum licenses across more than 100 countries.

&nbsp;&nbsp;&nbsp;&nbsp;• Supported tens of thousands of course titles across more than 500 subjects.

&nbsp;&nbsp;&nbsp;&nbsp;• Captured approximately 25.6 billion learning interactions<sup>(2)</sup>, generating proprietary insights that power precision learning and real-time personalized instruction.

------

&nbsp;&nbsp;&nbsp;&nbsp;• Over 7.5 million users of AI-enabled learning tools with 8 new tools launched over the past two years.

&nbsp;&nbsp;&nbsp;&nbsp;• AI Reader generated approximately 57 million learning interactions across approximately 2.4 million students since inception through May, accelerating from approximately 47 million interactions and approximately 2.2 million students in fiscal year 2026.

&nbsp;&nbsp;&nbsp;&nbsp;• Continued expansion of Evergreen delivery model, which is improving the customer experience and contributing to a record high Spring semester net promotor score for Higher Education.

&nbsp;&nbsp;&nbsp;&nbsp;• Launched critical new ELA curriculum that covers grades K-12 and aligns with the Science of Reading.

&nbsp;&nbsp;&nbsp;&nbsp;• Piloting a new Agentic AI tool that will make our precision education experience accessible as a trusted AI Agent for both education and non-education customers.

**Fourth Quarter and Fiscal Year 2026 Financial Highlights**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
|<br>**($ in thousands)** | **2026** | **2025** | **2026** | **2025** |
|  | **(unaudited)** | **(unaudited)** |  |  |
| Revenue | $463722 | $473262 | $2102781 | $2101299 |
| Cost of sales (excluding depreciation and amortization) | $74834 | $78393 | $401139 | $422294 |
| Operating and administrative expenses | $282023 | $292535 | $1080250 | $1066496 |
| Net income (loss) | $(50267) | $(156867) | $35320 | $(85839) |
| Adjusted EBITDA <sup>(1)</sup> | $130575 | $131651 | $744264 | $726790 |
| Net income (loss) margin | (10.8)% | (33.1)% | 1.7% | (4.1)% |
| Adjusted EBITDA Margin <sup>(1)</sup> | 28.2% | 27.8% | 35.4% | 34.6% |
| Adjusted net income (loss) <sup>(1)</sup> | $61167 | $(328084) | $375459 | $202350 |

---

**Fiscal Fourth Quarter Consolidated Financial Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;• Total revenue of $463.7 million, a decrease of 2.0% year-over-year, reflecting a smaller K-12 market opportunity, partially offset by strong Higher Education performance.

&nbsp;&nbsp;&nbsp;&nbsp;• Re-occurring revenue of $373.5 million, a decrease of 3.5% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;• Digital revenue of $392.7 million, a decrease of 2.1% year-over-year.

&nbsp;&nbsp;&nbsp;&nbsp;• GAAP gross profit of $388.9 million, representing a GAAP gross profit margin of 83.9%, an increase of nearly 50 basis points versus prior year.

&nbsp;&nbsp;&nbsp;&nbsp;• GAAP net income (loss) of $(50.3) million, compared to $(156.9) million in the prior-year period.

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(1)</sup> of $130.6 million, representing an Adjusted EBITDA margin<sup>(1)</sup> of 28.2%, an increase of nearly 40 basis points versus prior year.

**Fiscal Fourth Quarter and Full Year Segment Highlights**

**Higher Education** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Record high market share achieved, according to MPI.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fiscal Year 2026 revenue totaled $879.0 million, an increase of 12.3% year-over-year, while fiscal fourth quarter revenue grew 1.6% year-over-year supported by share gains, pricing favorability and beneficial enrollment trends.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fiscal Year 2026 re-occurring revenue totaled $734.4 million, an increase of 10.1% year-over-year, despite a 4.9% year-over-year decline in the fiscal fourth quarter due to mix.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net dollar retention of 114.0% driven by inclusive access upsell and cross-sell opportunities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evergreen delivery model continues to scale, representing 68% of Higher Education revenue.

**K-12** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Performance exceeded expectations despite the smaller expected K–12 market opportunity driven by procurement cycles.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fiscal Year 2026 revenue totaled $884.5 million, down 8.9% year-over-year and 10.4% in fiscal fourth quarter given the cyclical market comparison and higher capture rates last year.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fiscal Year 2026 re-occurring revenue totaled $619.7 million, an increase of 2.9% year-over-year, despite a 2.9% decline in the fiscal fourth quarter, on strong market capture and robust prior year sales.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Early 2026–2027 selling season indicators support fiscal year 2027 as the start of a multi-year market expansion opportunity, with trends that vary by market.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Well-positioned for multi-year growth via nationwide Science of Reading refresh, with strong early momentum from our Emerge, Summit, and Soar curriculum.

**Global Professional and International** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Global Professional delivered 4.0% digital growth in fiscal year 2026, driven by AI-powered medical solutions built on a foundation of trusted content.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• International revenue declined 7.3% in fiscal year 2026, with market headwinds giving way to new commercial opportunities in key markets and ALEKS Calculus expanding globally.

**Fiscal Year 2027 Guidance**

The following fiscal year 2027 guidance is forward-looking, and is based on the Company's current expectations. Actual results may differ materially from what is indicated below.

---

| | | |
|:---|:---|:---|
| | **Fiscal Year 2027 Guidance** | **Fiscal Year 2027 Guidance** |
| | **As of June 11, 2026** | **As of June 11, 2026** |
|<br>**($ in millions)** | **Low** | **High** |
| Revenue | $2115 | $2175 |
| Re-occurring Revenue | 1587 | 1627 |
| Adjusted EBITDA <sup>(1)</sup> | 750 | 790 |

---

**Share Repurchase Plan**

On June 2, 2026, our Board of Directors approved a share repurchase plan whereby, from time to time, the Company may repurchase up to $50 million of the Company's common stock.

**Earnings Conference Call and Webcast**

Today, June 11, 2026, at 8:30 a.m. ET, McGraw Hill will host a conference call via webcast to review fiscal year 2026 fourth quarter and full year results and provide a business update. The webcast will be hosted by Simon Allen, Chair of the Board of Directors, Philip Moyer, President and Chief Executive Officer, and Bob Sallmann, Executive Vice President and Chief Financial Officer, and will conclude with a question-and-answer session.

To access the live webcast or to view a replay, visit the Company's investor relations website at https://investors.mheducation.com/

The live question and answer portion of the call can be accessed by registering online at the Event Registration Page: https://events.q4inc.com/analyst/158045632?pwd=nJ0KYL1q at which time registrants will receive dial-in information as well as a conference ID. Registration can be completed in advance of the conference call.

**About McGraw Hill**

McGraw Hill (NYSE: MH) is a leading global provider of education solutions for preK-12, higher education and professional learning, supporting the evolving needs of millions of educators and students around the world. We provide trusted, high-quality content and personalized learning experiences that use data, technology and learning science to help students progress towards their goals. Through our commitment to fostering a culture of innovation and belonging, we are dedicated to improving outcomes and access to education for all. We have over 30 offices across North America, Asia, Australia, Europe, the Middle East and South America, and make our learning solutions available in more than 80 languages. The Company's fiscal year is the 52-week period ended March 31. Visit us at mheducation.com or find us on Facebook, Instagram, LinkedIn or X.

------

**Safe Harbor Statement** 

This press release includes statements that are, or may be deemed to be, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by the use of forward-looking terminology, including terms such as "believes," "estimates," "anticipates," "expects," "projects," "intends," "plans," "may," "will," "should" or "seeks," or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include, but are not limited to, statements regarding the Company's intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial condition, liquidity, prospects, growth, strategies and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties, as they relate to events and depend on circumstances that may or may not occur in the future. The Company's expectations, beliefs and projections are expressed in good faith, and the Company believes there is a reasonable basis for them; however, the Company cautions readers that forward-looking statements are not guarantees of future performance and that the Company's actual results of operations, financial condition and liquidity, and the developments in the industry in which the Company operates, may differ materially from those made in or suggested by the forward-looking statements contained in this press release. There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from the forward-looking statements contained in this press release, including those described under the headings "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and in other filings made with the U.S. Securities and Exchange Commission. In addition, even if our results of operations, financial condition and liquidity, and the developments in the industry in which we operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. Any forward-looking statements the Company makes in this press release speak only as of the date of such statement. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities law.

 <sup>(1)</sup> Non-GAAP Financial Measures

In addition to presenting financial results that have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), we have included in this release the following non-GAAP financial measures—EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted net income (loss), Adjusted basic and diluted earnings (loss) per share, Adjusted operating and administrative expenses, Adjusted selling and marketing expenses, Adjusted general and administrative expenses, Adjusted research and development expenses and Net Leverage Ratio. All such financial measures are not required by or presented in accordance with GAAP. We believe that these non-GAAP financial measures are useful in evaluating our business and the underlying trends that affect our performance. The Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. We include these non-GAAP financial measures in this release because management uses them to assess our performance. We believe that they reflect the underlying trends and indicators of our business and allow management to focus on the most meaningful indicators of our continuous operational performance. Although we believe these measures are useful for investors for the same reasons, readers of the financial statements herein should note that these measures are not a substitute for GAAP financial measures or disclosures. Each of these measures is not a recognized term under GAAP and does not purport to be an alternative to net income (loss), or any other measure derived in accordance with GAAP as a measure of operating performance, or to cash flows from operations as a measure of liquidity. Such measures are presented for supplemental information purposes only, have limitations as analytical tools and should not be considered in isolation or as substitute measures for our results as reported under GAAP. Management uses non-GAAP financial measures to supplement GAAP results to provide a more complete understanding of the factors and trends affecting our business, rather than evaluating GAAP results alone. Because not all companies use identical calculations, our measures may not be comparable to other similarly titled measures of other companies, and our use of these measures varies from others in our industry. Such measures are not intended to be a measure of cash available for management's discretionary use, as they may not capture actual cash obligations associated with interest payments, other debt service requirements and taxes.

------

Because of these limitations, we rely primarily on our GAAP results and use these non-GAAP measures only supplementally. See "Reconciliations of Non-GAAP Financial Measures" in the "Supplemental Information" section below and "Management's Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures" in our Annual Report on Form 10-K filed on June 11, 2026, for reconciliations of non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP.

<sup>(2)</sup> Learning interactions measures the volume of user-driven educational activities across McGraw Hill platforms, including answering questions, completing assignments, and engaging with learning content. This data captures activity across K-12 platforms (Open Learning, ConnectED, ALEKS), Higher Education (Smartbook, Connect), and Enterprise IDM. For the fiscal year ended March 31, 2026, coverage expanded to include A3K Literacy, Actively Learn, and additional Connect data.

**Forward-Looking Non-GAAP Financial Measures**

This press release contains forward-looking estimates of Adjusted EBITDA for fiscal year 2027. We provide this non-GAAP measure to investors on a prospective basis for the same reasons (as set forth above) that we provide it to investors on a historical basis. We are unable to provide a reconciliation of our forward-looking estimate of fiscal year 2027 net income (loss) to a forward-looking estimate of fiscal year 2027 Adjusted EBITDA because certain information needed to make a reasonable forward-looking estimate of net income (loss) for fiscal year 2027 is unreasonably difficult to predict and estimate and is often dependent on future events that may be uncertain or outside of our control. In addition, we believe such reconciliations would imply a degree of precision that would be confusing or misleading to investors. The unavailable information could have a significant impact on our future financial results. Our forward-looking estimates of both GAAP and non-GAAP measures of our financial performance may differ materially from our actual results and should not be relied upon as statements of fact.

---

| | |
|:---|:---|
| **Investor Contacts:** | **Media Contacts:** |
| Danielle Kloeblen | Cathy McManus |
| Danielle.kloeblen@mheducation.com | Cathy.mcmanus@mheducation.com  |
| Zack Ajzenman | Tyler Reed |
| Zack.ajzenman@mheducation.com | Tyler.reed@mheducation.com |
| Lizzie Kenter | |
| Lizzie.kenter@mheducation.com | |

---

------

**MCGRAW HILL, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Dollars in thousands, except for share and per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2025** | **2026** | **2025** |
| | **(unaudited)** | **(unaudited)** | | |
| **Revenue** | $463722 | $473262 | $2102781 | $2101299 |
| Cost of sales (excluding depreciation and amortization) | 74834 | 78393 | 401139 | 422294 |
| Gross profit | 388888 | 394869 | 1701642 | 1679005 |
| **Operating expenses** |  |  |  |  |
| Operating and administrative expenses | 282023 | 292535 | 1080250 | 1066496 |
| Depreciation | 19767 | 16240 | 81985 | 66688 |
| Amortization of intangibles | 54460 | 58322 | 223627 | 239014 |
| Impairment charge | 39000 |  | 39000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 395250 | 367097 | 1424862 | 1372198 |
| Operating income (loss) | (6362) | 27772 | 276780 | 306807 |
| Interest expense (income), net | 45154 | 63547 | 207226 | 293446 |
| (Gain) loss on extinguishment of debt | 1222 |  | 25766 | 2719 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income (loss) from operations before taxes | (52738) | (35775) | 43788 | 10642 |
| Income tax provision (benefit) | (2471) | 121092 | 8468 | 96481 |
| **Net income (loss)** | $**(50267)** | $**(156867)** | $**35320** | $**(85839)** |
| Basic earnings (loss) per share | $(0.26) | $(0.94) | $0.19 | $(0.52) |
| Diluted earnings (loss) per share | $(0.26) | $(0.94) | $0.19 | $(0.52) |

---

_________________

&nbsp;&nbsp;&nbsp;&nbsp;(1) See "Supplemental Information—Reconciliations of Non-GAAP Financial Measures; Non-GAAP operating and administrative expenses" for a breakdown of our GAAP operating and administrative expenses and a reconciliation to the corresponding Non-GAAP financial measure.

------

**MCGRAW HILL, INC. AND SUBSIDIARIES** 

**CONSOLIDATED BALANCE SHEETS**

**(Dollars in thousands, except for share data)**

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2025** |
| **Assets** | | |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $253519 | $389830 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance for credit losses of $14,517 and $13,521 as of March 31, 2026 and 2025, respectively | 362483 | 338426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 195022 | 174018 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid and other current assets | 162625 | 150357 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 973649 | 1052631 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product development costs, net | 285970 | 222182 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 90421 | 95197 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 2522595 | 2557595 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other intangible assets, net | 1227253 | 1454185 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 8572 | 7983 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 44836 | 49661 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | 332225 | 318326 |
| **Total assets** | $**5485521** | $**5757760** |
| **Liabilities and stockholders' equity (deficit)** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $126701 | $146742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued royalties | 81436 | 71457 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | 108434 | 124954 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 835357 | 794031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt | 13170 | 13170 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 8365 | 8042 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 93086 | 172023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 1266549 | 1330419 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | 2560698 | 3164551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 15214 | 15656 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred revenue | 836001 | 882156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 57301 | 64737 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-current liabilities | 23540 | 19997 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 4759303 | 5477516 |
| Commitments and contingencies |  |  |
| **Stockholders' equity (deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Class A voting common stock, par value $0.01 per share; 186,471,212 shares authorized, 165,160,216 shares issued and outstanding as of March 31, 2025 |  | 1652 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class B non-voting common stock, par value $0.01 per share; 14,384,922 shares authorized, 1,451,303 shares issued and outstanding as of March 31, 2025 |  | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common Stock, par value $0.01 per share; 2,000,000,000 shares authorized, 191,146,027 shares issued and outstanding as of March 31, 2026; and no shares authorized, issued and outstanding as of March 31, 2025 | 1911 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1972702 | 1562204 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (1245880) | (1281200) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) | (2515) | (2426) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity (deficit) | 726218 | 280244 |
| **Total liabilities and stockholders' equity (deficit)** | $**5485521** | $**5757760** |

---

------

**MCGRAW HILL, INC. AND SUBSIDIARIES** 

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Dollars in thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2025** | **2026** | **2025** |
| | **(unaudited)** | **(unaudited)** | | |
| **Operating activities** |  |  |  |  |
| Net income (loss) | $(50267) | $(156867) | $35320 | $(85839) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation (including amortization of technology costs) | 19767 | 16240 | 81985 | 66688 |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | 54460 | 58322 | 223627 | 239014 |
| &nbsp;&nbsp;&nbsp;Amortization of product development costs | 11344 | 11952 | 56306 | 56655 |
| &nbsp;&nbsp;&nbsp;Amortization of deferred royalties | 8532 | 10639 | 76186 | 75919 |
| &nbsp;&nbsp;&nbsp;Amortization of deferred commission costs | 6466 | 6357 | 22449 | 19092 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 1986 |  | 33723 |  |
| &nbsp;&nbsp;&nbsp;Credit losses on accounts receivable | 2838 | 5324 | 2309 | 2768 |
| &nbsp;&nbsp;&nbsp;Unrealized (gain) loss on interest rate cap |  |  |  | 235 |
| &nbsp;&nbsp;&nbsp;Inventory obsolescence | 886 | 3229 | 9186 | 13013 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | (1900) | (286) | (1055) | (1470) |
| &nbsp;&nbsp;&nbsp;Amortization of debt discount | 3053 | 5733 | 13000 | 20722 |
| &nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 1199 | 1713 | 4943 | 10495 |
| &nbsp;&nbsp;&nbsp;(Gain) loss on extinguishment of debt | 1222 |  | 25766 | 2719 |
| &nbsp;&nbsp;&nbsp;Impairment charge | 39000 |  | 39000 |  |
| Changes in operating assets and liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | (123535) | (12057) | (22902) | (12490) |
| &nbsp;&nbsp;&nbsp;Inventories | (26335) | (25697) | (29467) | 26299 |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | (35152) | 27618 | (127979) | (99627) |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 4003 | 45389 | (21265) | 85541 |
| &nbsp;&nbsp;&nbsp;Deferred revenue | (25138) | (72011) | (6174) | 166550 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | (42069) | 16201 | (84192) | 46854 |
| &nbsp;&nbsp;&nbsp;Other changes in operating assets and liabilities, net | 3516 | 17016 | 407 | 13146 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) operating activities | (146124) | (41185) | 331173 | 646284 |
| **Investing activities** |  |  |  |  |
| Product development expenditures | (42321) | (29524) | (119001) | (90000) |
| Capital expenditures | (23823) | (28441) | (84862) | (71062) |
| Acquisition of EssayPop |  | (6000) |  | (6000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) investing activities | (66144) | (63965) | (203863) | (167062) |
| **Financing activities** |  |  |  |  |
| Borrowings on 2024 Secured Notes |  |  |  | 650000 |
| Payment of A&E Term Loan Facility | (10000) | (53293) | (605575) | (156585) |
| Payment of Term Loan Facility |  |  |  | (754875) |
| Repurchase of 2022 Unsecured Notes | (39895) |  | (39895) |  |
| Payment of deferred financing costs |  |  |  | (24027) |
| Payment of finance lease obligations | (810) | (1485) | (6722) | (9193) |
| Proceeds from issuance of common stock in Initial Public Offering, net of underwriting discounts |  |  | 392862 |  |
| Deferred Initial Public Offering costs |  |  | (7037) |  |
| Issuance of Common Stock | 1500 |  | 1500 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by (used for) financing activities | (49205) | (54778) | (264867) | (294680) |
| Effect of exchange rate changes on cash | 600 | 774 | 1246 | 1670 |
| Net change in cash and cash equivalents | (260873) | (159154) | (136311) | 186212 |
| Cash and cash equivalents, at the beginning of the period | 514392 | 548984 | 389830 | 203618 |
| Cash and cash equivalents, at the end of the period | $253519 | $389830 | $253519 | $389830 |
| **Supplemental disclosures** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest expense | $83253 | $101338 | $207932 | $274730 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes | 2750 | 13519 | 76582 | 46920 |

---

------

**Supplemental Information**

**Reconciliations of Non-GAAP Financial Measures**

***EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin***

"EBITDA" is defined as net income (loss) from continuing operations plus interest expense (income), net, income tax provision (benefit), depreciation and amortization.

"Adjusted EBITDA" is defined as net income (loss) from continuing operations plus interest expense (income), net, income tax provision (benefit), depreciation and amortization, restructuring and cost savings implementation charges, the effects of the application of purchase accounting, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), impairment charges, transaction and integration costs, stock-based compensation, (gain) loss on extinguishment of debt and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

Further, although not included in the calculation of Adjusted EBITDA below, we may at times add estimated cost savings and operating synergies related to operational changes ranging from acquisitions or dispositions to restructurings, and exclude one-time transition expenditures.

"Adjusted EBITDA Margin" is calculated by dividing Adjusted EBITDA by total revenue.

The following table presents a reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP financial measure for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2025** | **2026** | **2025** |
| **($ in thousands)** | **(unaudited)** | **(unaudited)** |  |  |
| Net income (loss) | $(50267) | $(156867) | $35320 | $(85839) |
| Interest expense (income), net | 45154 | 63547 | 207226 | 293446 |
| Income tax provision (benefit) | (2471) | 121092 | 8468 | 96481 |
| Depreciation, amortization and product development amortization | 85571 | 86514 | 361918 | 362357 |
| **EBITDA**  | $**77987** | $**114286** | $**612932** | $**666445** |
| Restructuring and cost savings implementation charges <sup>(a)</sup> | 2402 | 7616 | 11176 | 24626 |
| Advisory fees <sup>(b)</sup> |  | 2500 | 3125 | 10000 |
| Impairment charge <sup>(c)</sup> | 39000 |  | 39000 |  |
| Transaction and integration costs <sup>(d)</sup> | 373 | 462 | 1191 | 2982 |
| Stock-based compensation <sup>(e)</sup> | 1986 |  | 33723 |  |
| Gain (loss) on extinguishment of debt <sup>(f)</sup> | 1222 |  | 25766 | 2719 |
| Other <sup>(g)</sup> | 7605 | 6787 | 17351 | 20018 |
| **Adjusted EBITDA** <sup>(h)</sup>  | $**130575** | $**131651** | $**744264** | $**726790** |
| Total Revenue | $463722 | $473262 | $2102781 | $2101299 |
| Net income (loss) margin | (10.8)% | (33.1)% | 1.7% | (4.1)% |
| Adjusted EBITDA Margin | 28.2% | 27.8% | 35.4% | 34.6% |

---

&nbsp;&nbsp;&nbsp;&nbsp;__________________

(a) Represents severance and other expenses associated with headcount reductions and other cost savings initiated as part of our restructuring initiatives.

(b) For the fiscal year ended March 31, 2026, represents the pro rata portion of the annual $10.0 million advisory fee paid to Platinum Advisors pursuant to the Advisory Agreement through its termination on July 25, 2025 in connection with the

------

consummation of our initial public offering. For the fiscal year ended March 31, 2025, represents $10.0 million of annual advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement. For the three months ended March 31, 2025, represents the quarterly portion of such annual advisory fee.

(c) For the three months ended March 31, 2026 and the fiscal year ended March 31, 2026, we recorded an impairment charge of $39.0 million, related to our International goodwill and indefinite-lived intangible trademark.

(d) This primarily represents transaction and integration costs associated with acquisitions.

(e) Represents stock-based compensation expense related to awards granted to our employees, directors and consultants under the Company's long-term incentive plans.

(f) For the three months ended March 31, 2026, the amount represents accelerated amortization of debt discount and deferred financing costs associated with the repayment of $40.0 million face value of the 2022 Unsecured Notes and $6.7 million of debt outstanding under the A&E Term Loan Facility.

For the fiscal year ended March 31, 2026, the amount represents accelerated amortization of debt discount and deferred financing costs related to (i) the repayment of $385.7 million of debt outstanding under the A&E Term Loan Facility using net proceeds from our initial public offering on July 25, 2025, (ii) the repayment of an additional $206.7 million of debt outstanding under the A&E Term Loan Facility during the second half of fiscal year 2026, and (iii) the repayment of $40.0 million face value of the 2022 Unsecured Notes during the fourth fiscal quarter of 2026.

For the fiscal year ended March 31, 2025, the amount represents accelerated amortization of debt discount and deferred financing costs associated with the August 6, 2024 refinancing of the Term Loan Facility.

(g) For the three months ended March 31, 2026 and 2025, this amount represents (i) foreign currency exchange transaction impact of $(0.1) million and $(0.3) million, respectively, (ii) non-recurring expenses related to strategic initiatives, including marketing, consulting, and non-operational costs associated with the market introduction of a new product launch of $3.7 million and $1.2 million, respectively, (iii) reimbursements of expenses paid to Platinum Advisors incurred in connection with its services under the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering) of $0.5 million and $0.2 million, respectively, (iv) non-recurring transaction-related costs associated with our initial public offering that were expensed as incurred of nil and $1.8 million, respectively, (v) lease termination costs of nil and $3.3 million, respectively, associated with the early exit of a leased property in connection with the strategic rationalization of our real estate properties to optimize cost efficiency, and (vi) the impact of additional insignificant earnings or charges resulting from matters that we do not consider indicative of our ongoing operations of $3.5 million and $0.6 million, respectively, that are primarily related to individually insignificant miscellaneous items, including third-party consulting and advisory fees associated with system and process rationalization initiatives and certain additional payments related to incremental insurance premiums and policies as a result of the Platinum acquisition that did not renew after the consummation of our initial public offering.

For the fiscal years ended March 31, 2026 and 2025, the amount represents (i) foreign currency exchange transaction impact of $(2.3) million and $1.3 million, respectively, (ii) non-recurring expenses related to strategic initiatives, including marketing, consulting, and non-operational costs associated with the market introduction of a new product launch of $9.2 million and $4.3 million, respectively, (iii) reimbursements of expenses paid to Platinum Advisors incurred in connection with its services under the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering) of $0.8 million and $0.6 million, respectively, (iv) non-recurring transaction-related costs associated with our initial public offering that were expensed as incurred of $2.8 million and $4.9 million, respectively, (v) lease termination costs of nil and $3.3 million, respectively, associated with the early exit of a leased property in connection with the strategic rationalization of our real estate properties to optimize cost efficiency, (vi) post-acquisition compensation expense of nil and $0.6 million, respectively, associated with the acquisition of Boards & Beyond, and (vii) the impact of additional insignificant earnings or charges resulting from matters that we do not consider indicative of our ongoing operations of $6.9 million and $5.0 million, respectively, primarily related to individually insignificant miscellaneous items, including asset dispositions, third-party consulting and advisory fees associated with system and process rationalization initiatives, as well as certain additional payments related to incremental insurance premiums and policies as a result of the Platinum acquisition that did not renew after the consummation of our initial public offering.

(h) The purchase accounting adjustment included in the definition of Adjusted EBITDA is not presented in the table above, as there were no such charges recognized during the three months ended March 31, 2026 and 2025 and the fiscal years ended March 31, 2026 and 2025.

***Adjusted net income (loss) and Adjusted basic and diluted earnings (loss) per share***

"Adjusted net income (loss)" is defined as net income (loss) from continuing operations adjusted to exclude amortization of intangible assets, restructuring and cost savings implementation charges, the effects of the application of purchase accounting, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), impairment charges, transaction and integration costs, stock-based compensation, (gain) loss on extinguishment of debt and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations and the related tax impact of those adjustments.

------

"Adjusted basic and diluted earnings (loss) per share" is calculated by dividing Adjusted net income (loss) by the basic and diluted weighted average shares outstanding.

The following table presents a reconciliation of Adjusted net income (loss) and Adjusted basic and diluted earnings (loss) per share to the most directly comparable GAAP financial measure for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2025** | **2026** | **2025** |
| **($ in thousands)** | **(unaudited)** | **(unaudited)** |  |  |
| Net income (loss) | $(50267) | $(156867) | $35320 | $(85839) |
| Amortization of intangible assets <sup>(1)</sup> | 54298 | 58125 | 222932 | 238240 |
| Restructuring and cost savings implementation charges <sup>(2)</sup> | 2402 | 7616 | 11176 | 24626 |
| Advisory fees <sup>(2)</sup> |  | 2500 | 3125 | 10000 |
| Impairment charge <sup>(2)</sup> | 39000 |  | 39000 |  |
| Transaction and integration costs <sup>(2)</sup> | 373 | 462 | 1191 | 2982 |
| Stock-based compensation <sup>(2)</sup> | 1986 |  | 33723 |  |
| Gain (loss) on extinguishment of debt <sup>(2)</sup> | 1222 |  | 25766 | 2719 |
| Other <sup>(2)</sup> | 7605 | 6787 | 17351 | 20018 |
| Tax impact of adjustments<sup>(3)</sup> | 4548 | (246707) | (14125) | (10396) |
| **Adjusted net income (loss)** | $**61167** | $**(328084)** | $**375459** | $**202350** |
| Basic earnings (loss) per share | $(0.26) | $(0.94) | $0.19 | $(0.52) |
| Diluted earnings (loss) per share | $(0.26) | $(0.94) | $0.19 | $(0.52) |
| Adjusted basic earnings (loss) per share | $0.32 | $(1.97) | $2.05 | $1.21 |
| Adjusted diluted earnings (loss) per share<sup>(4)</sup> | $0.32 | $(1.97) | $2.04 | $1.21 |
| Basic weighted-average shares outstanding | 191066548 | 166611519 | 183466677 | 166611519 |
| Diluted weighted-average shares outstanding | 191066548 | 166611519 | 183670022 | 166611519 |

---

_____________

(1) Represents amortization of definite-lived acquired intangible assets.

(2) Represents the same adjustments used in calculating EBITDA and Adjusted EBITDA.

(3) Represents the tax impact of these adjustments, which are pre-tax, based upon the effective income tax rate.

(4) For the three months ended March 31, 2026, the Company reported a net loss and, accordingly, all potentially dilutive securities were considered anti-dilutive and excluded from the calculation of diluted earnings (loss) per share. However, because the Company reported Adjusted net income for the same period, these potentially dilutive securities were included in the calculation of Adjusted diluted earnings (loss) per share, resulting in diluted weighted-average shares outstanding of 191,105,182. There were no potentially dilutive securities issued during the three months ended March 31, 2025.

***Non-GAAP operating and administrative expenses***

"Adjusted operating and administrative expenses" is defined as GAAP operating and administrative expenses adjusted to exclude restructuring and cost savings implementation charges, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), transaction and integration costs, stock-based compensation, amortization of product development costs and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

"Adjusted selling and marketing expenses" is defined as GAAP selling and marketing expenses adjusted to exclude stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

------

"Adjusted general and administrative expenses" is defined as GAAP general and administrative expenses adjusted to exclude restructuring and cost savings implementation charges, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), transaction and integration costs, stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

"Adjusted research and development expenses" is defined as GAAP research and development expenses adjusted to exclude stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

The following table presents a reconciliation of these non-GAAP operating and administrative expenses to the most directly comparable GAAP financial measure for the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2025** | **2026** | **2025** |
| **($ in thousands)** | **(unaudited)** | **(unaudited)** |  |  |
| **Operating and administrative expenses** | $282023 | $292535 | $1080250 | $1066496 |
| Restructuring and cost savings implementation charges | (2402) | (7616) | (11176) | (24626) |
| Advisory fees |  | (2500) | (3125) | (10000) |
| Transaction and integration costs | (373) | (462) | (1191) | (2982) |
| Amortization of product development costs | (11344) | (11952) | (56306) | (56655) |
| Stock-based compensation | (1986) |  | (33723) |  |
| Other | (7605) | (6787) | (17351) | (20018) |
| **Adjusted operating and administrative expenses** <sup>(1)</sup> | $**258313** | $**263218** | $**957378** | $**952215** |
| Selling and marketing | $101565 | $104375 | $378719 | $380199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | (19) |  | (1180) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (2856) | (743) | (6922) | (3210) |
| **Adjusted selling and marketing expenses** <sup>(1)</sup> | $**98690** | $**103632** | $**370617** | $**376989** |
| General and administrative | $95485 | $88853 | $368972 | $345213 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and cost savings implementation charges | (2402) | (7616) | (11176) | (24626) |
| &nbsp;&nbsp;&nbsp;&nbsp;Advisory fees |  | (2500) | (3125) | (10000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction and integration costs | (373) | (462) | (1191) | (2982) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | (1919) |  | (27428) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (4010) | (5655) | (8500) | (15747) |
| **Adjusted general and administrative expenses** <sup>(1)</sup> | $**86781** | $**72620** | $**317552** | $**291858** |
| Research and development | $73629 | $87355 | $276253 | $284429 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | (48) |  | (5115) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (739) | (389) | (1929) | (1061) |
| **Adjusted research and development expenses** <sup>(1)</sup> | $**72842** | $**86966** | $**269209** | $**283368** |

---

_____________

(1) We calculate each of these measures by using the same adjustments used in calculating EBITDA and Adjusted EBITDA to the extent such items are included in the corresponding GAAP operating and administrative expense category.

------

***Net Leverage Ratio***

"Net Leverage Ratio" is calculated by dividing net debt as of the most recent balance sheet date by the Last Twelve Months ("LTM") Adjusted EBITDA. Net debt is defined as Gross Debt, net of cash and cash equivalents. Gross Debt is defined as the total amount of principal borrowings outstanding.

LTM is defined as the twelve-month period ended on the last day of the most recently completed fiscal quarter. LTM Adjusted EBITDA is equal to Adjusted EBITDA for the fiscal year ended March 31, 2026.

---

| | |
|:---|:---|
| | **As of March 31,** |
|<br>**($ in thousands)** | **2026** |
| A&E Term Loan Facility due 2031 | $554840 |
| 2022 Secured Notes due 2028 | 828466 |
| 2024 Secured Notes due 2031 | 650000 |
| First Lien Indebtedness | $2033352 |
| 2022 Unsecured Notes due 2029 | 599034 |
| Gross Debt | $2632386 |
| Cash and cash equivalents | (253519) |
| Net Debt | $2378867 |
| LTM Adjusted EBITDA <sup>(1)</sup> | $744264 |
| Net Leverage Ratio <sup>(2)</sup> | 3.2x |

---

__________

(1) LTM Adjusted EBITDA is equal to Adjusted EBITDA for the fiscal year ended March 31, 2026.

(2) In addition to the Net Leverage Ratio, the Company is subject to a Consolidated First Lien Net Leverage Ratio springing covenant, pursuant to its credit agreement. The Consolidated First Lien Net Leverage Ratio is calculated by dividing Consolidated First Lien Secured Debt by LTM Consolidated Adjusted EBITDA, as such terms are defined in our credit agreements. As of March 31, 2026, the Consolidated First Lien Net Leverage Ratio was 2.4x. The Consolidated First Lien Secured Debt was $1,795,896 as of March 31, 2026, and is defined as First Lien Indebtedness of $2,033,352 plus capital lease obligations of $16,063, net of cash and cash equivalents of $253,519. LTM Consolidated Adjusted EBITDA is Consolidated Adjusted EBITDA for the fiscal year ended March 31, 2026 of $751,803. Consolidated Adjusted EBITDA differs from Adjusted EBITDA presented elsewhere herein and is defined in our credit agreements.

------

**Key Operating Metrics**

***Re-occurring Revenue and Transactional Revenue***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
| | **Re-occurring<br>Revenue** | **Transactional<br>Revenue** | **Total** | **Re-occurring<br>Revenue** | **Transactional<br>Revenue** | **Total** |
|<br><br>**($ in thousands)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| &nbsp;&nbsp;K-12 | $109142 | $17071 | $126213 | $112384 | $28446 | $140830 |
| &nbsp;&nbsp;Higher Education | 217106 | 41144 | 258250 | 228307 | 25807 | 254114 |
| &nbsp;&nbsp;Global Professional | 25141 | 13729 | 38870 | 24480 | 13876 | 38356 |
| &nbsp;&nbsp;International | 22110 | 18705 | 40815 | 21839 | 21186 | 43025 |
| &nbsp;&nbsp;Other |  | (426) | (426) |  | (3063) | (3063) |
| **Total Revenue** | $**373499** | $**90223** | $**463722** | $**387010** | $**86252** | $**473262** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
|<br>**($ in thousands)** | **Re-occurring<br>Revenue** | **Transactional<br>Revenue** | **Total** | **Re-occurring<br>Revenue** | **Transactional<br>Revenue** | **Total** |
| &nbsp;&nbsp;K-12 | $619725 | $264755 | $884480 | $602040 | $368444 | $970484 |
| &nbsp;&nbsp;Higher Education | 734353 | 144601 | 878954 | 666748 | 115862 | 782610 |
| &nbsp;&nbsp;Global Professional | 98746 | 51330 | 150076 | 95094 | 54494 | 149588 |
| &nbsp;&nbsp;International | 88143 | 98542 | 186685 | 92959 | 108443 | 201402 |
| &nbsp;&nbsp;Other |  | 2586 | 2586 |  | (2785) | (2785) |
| **Total Revenue** | $**1540967** | $**561814** | $**2102781** | $**1456841** | $**644458** | $**2101299** |

---

***Remaining Performance Obligation (RPO)***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** | **March 31, 2025** |
|<br>**($ in thousands)** | **Current** | **Non-current** | **Total** | **Current** | **Non-current** | **Total** |
| **RPO by Segment:** | | | | | | |
| &nbsp;&nbsp;K-12 | $477183 | $772190 | $1249373 | $457353 | $822232 | $1279585 |
| &nbsp;&nbsp;Higher Education | 268649 | 53350 | 321999 | 247685 | 49631 | 297316 |
| &nbsp;&nbsp;Global Professional | 58186 | 7791 | 65977 | 54949 | 7399 | 62348 |
| &nbsp;&nbsp;International | 30394 | 2670 | 33064 | 30513 | 2894 | 33407 |
| &nbsp;&nbsp;Other | 945 |  | 945 | 3531 |  | 3531 |
| **Total RPO**  | $**835357** | $**836001** | $**1671358** | $**794031** | $**882156** | $**1676187** |

---

***Net Dollar Retention***

Net dollar retention "NDR" is calculated by dividing (a) the digital subscription amounts invoiced to existing customers during the year, inclusive of changes in enrollment, price changes and attrition by (b) the digital subscription amounts invoiced to such customers for the comparable prior year.

------

**Digital and Print Revenue**

***Disaggregation of Revenue - Print and Digital***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
| | **Digital** | **Print (1)** | **Total** | **Digital** | **Print (1)** | **Total** |
|<br><br>**($ in thousands)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** | **(unaudited)** |
| **Revenue by Segment:** |  |  |  |  |  |  |
| &nbsp;&nbsp;K-12 | $98898 | $27315 | $126213 | $102030 | $38800 | $140830 |
| &nbsp;&nbsp;Higher Education | 241799 | 16451 | 258250 | 249100 | 5014 | 254114 |
| &nbsp;&nbsp;Global Professional | 27577 | 11293 | 38870 | 26254 | 12102 | 38356 |
| &nbsp;&nbsp;International | 24442 | 16373 | 40815 | 23624 | 19401 | 43025 |
| &nbsp;&nbsp;Other (2) |  | (426) | (426) |  | (3063) | (3063) |
| **Total Revenue** | $**392716** | $**71006** | $**463722** | $**401008** | $**72254** | $**473262** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** | **Year Ended March 31,** |
| | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
|<br>**($ in thousands)** | **Digital** | **Print (1)** | **Total** | **Digital** | **Print (1)** | **Total** |
| **Revenue by Segment:** |  |  |  |  |  |  |
| &nbsp;&nbsp;K-12 | $429644 | $454836 | $884480 | $430546 | $539938 | $970484 |
| &nbsp;&nbsp;Higher Education | 799898 | 79056 | 878954 | 723066 | 59544 | 782610 |
| &nbsp;&nbsp;Global Professional | 107120 | 42956 | 150076 | 102996 | 46592 | 149588 |
| &nbsp;&nbsp;International | 96986 | 89699 | 186685 | 102719 | 98683 | 201402 |
| &nbsp;&nbsp;Other (2) |  | 2586 | 2586 |  | (2785) | (2785) |
| **Total Revenue** | $**1433648** | $**669133** | $**2102781** | $**1359327** | $**741972** | $**2101299** |

---

___________________

(1) Print revenue contains print and multi-year print products.

(2) Includes in-transit product sales and intersegment revenue adjustments that are not included within segment revenues reviewed by the Company's Chief Operating Decision Maker.